FDA Inspection 1272730 — Pharmcore Inc. dba Hallandale Pharmacy

Pharmcore Inc. dba Hallandale Pharmacy — FEI 3014480778

The FDA completed an inspection of Pharmcore Inc. dba Hallandale Pharmacy on June 13, 2025 in Fort Lauderdale, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 13, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Lauderdale, FL (United States)

Citations

IDCFRDescription
22742FDCA 501(a)(2)(A)Exposed to lower quality air/ISO 5
22766FDCA 501(a)(2)(A)Inadequate smoke studies